Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment for diabetes and obesity.

US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...

U.S. lawmakers propose banning DeepSeek's app on government devices over security concerns, similar to the TikTok ban, citing links to China's government. Roblox faces a significant drop after ...

If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

As founder of Coatue Management, Philippe Laffont oversees $26.9 billion invested in more than 80 stocks, and though he buys ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.

Mounjaro, or tirzepatide ... but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Truist Securities, TD Cowen, Citigroup Inc. ( C) and Canaccord Genuity all also rate BSX "buy," while JPMorgan Chase & Co. ( ...

Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular ...

The company sells tirzepatide, approved for weight loss under the name Zepbound and approved for type 2 diabetes under the name Mounjaro. Doctors have prescribed ... This player's units include ...

UnitedHealth Group, AbbVie, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks refer to equities in companies that are ...

Pharmacies have been given instructions by the General Pharmaceutical Council on new steps they must follow before ...